PhaseRx, Inc. (PZRX) financial statements (2022 and earlier)

Company profile

Business Address 410 WEST HARRISON STREET
SEATTLE, WA 98119
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:15,500
Cash and cash equivalents9,983
Short-term investments5,496
Other undisclosed cash, cash equivalents, and short-term investments21
Other undisclosed current assets677
Total current assets:16,177
Noncurrent Assets
Property, plant and equipment271
Total noncurrent assets:271
TOTAL ASSETS:16,448
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,448
Accounts payable515
Accrued liabilities884
Interest and dividends payable49
Debt576
Total current liabilities:2,024
Noncurrent Liabilities
Long-term debt and lease obligation5,127
Long-term debt, excluding current maturities5,127
Total noncurrent liabilities:5,127
Total liabilities:7,151
Stockholders' equity
Stockholders' equity attributable to parent9,297
Common stock1
Additional paid in capital78,773
Accumulated other comprehensive income3
Accumulated deficit(69,480)
Total stockholders' equity:9,297
TOTAL LIABILITIES AND EQUITY:16,448

Income statement (P&L) ($ in thousands)

12/31/2016
Operating expenses(18,330)
Operating loss:(18,330)
Nonoperating expense(1,807)
Interest and debt expense(2,058)
Net loss:(22,195)
Other undisclosed net income attributable to parent2,058
Net loss available to common stockholders, diluted:(20,137)

Comprehensive Income ($ in thousands)

12/31/2016
Net loss:(22,195)
Comprehensive loss:(22,195)
Other undisclosed comprehensive income, net of tax, attributable to parent2,061
Comprehensive loss, net of tax, attributable to parent:(20,134)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: